Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Wuxi Biologics Co Ltd
EIR
•Wuxi Biologics Co Ltd•April 8, 2019

Wuxi Biologics Co Ltd – FDA EIR, Apr 8, 2019

Record Details

An FDA Good Manufacturing Practice (GMP) inspection of Wuxi Biologics Co Ltd, located in Wuxi, China, occurred from April 8 to April 16, 2019. This inspection focused on the manufacturing of biological therapeutic drug substance and sterile liquid drug products, conducted under established CPGMs for Drug Manufacturing Inspections, Sterile Drug Process Inspections, and Biological Therapeutic Drug Products, referencing Q7 guidelines. The inspection identified several deficiencies, resulting in an FDA Form 483. Key violations included the company's failure to adhere to established Standard Operating Procedures (SOPs), inadequate implementation of Corrective and Preventive Actions (CAPAs) to address negative trend data, insufficient retention of required samples, and incomplete evaluation of analytical methods. These findings are consistent with some issues from a previous 2017 inspection. In response to the current findings, company management initiated corrective actions during the inspection and committed to providing a formal written response to the FDA. The inspection was classified as "Voluntary Action Indicated" (VAI) and routine surveillance, indicating that the firm is expected to voluntarily correct the observed deficiencies and provide a written explanation of how they will be addressed.

Company
Wuxi Biologics Co Ltd
Inspection date
April 8, 2019
Product type
drugs
People
  • Christopher T. Middendorf (Senior Director Technical)
  • Zhisheng Chen (recipient)
  • Kevin A. Gonzalez (Branch Chief, Foreign Pharmaceutical Quality Inspection at FDA)
View Company Profile

ID · 526d92cf-0cca-4b1c-870b-888c1217bf8f

Other documents for Wuxi Biologics Co Ltd
  • 483 - 2024-06-04June 4, 2024
  • 483 - 2023-05-09May 9, 2023
  • 483 - 2021-04-02April 2, 2021
  • EIR - 2021-04-02April 2, 2021
  • 483 - 2019-04-16April 16, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wuxi Biologics Co Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.